Constantinos Giaginis
Constantinos Giaginis
Associate Professor of Human Nutrition, Wellness and Health, University of the Aegean, Greece
Verified email at
Cited by
Cited by
DNA repair systems as targets of cadmium toxicity
C Giaginis, E Gatzidou, S Theocharis
Toxicology and applied pharmacology 213 (3), 282-290, 2006
Current clinical status on the preventive effects of cranberry consumption against urinary tract infections
I Vasileiou, A Katsargyris, S Theocharis, C Giaginis
Nutrition Research 33 (8), 595-607, 2013
Alternative measures of lipophilicity: From octanol-water partitioning to IAM retention
C Giaginis, A Tsantili-Kakoulidou
Journal of Pharmaceutical Sciences 97 (8), 2984-3004, 2008
Current state of the art in HPLC methodology for lipophilicity assessment of basic drugs. A review.
C Giaginis, A Tsantili-Kakoulidou
Journal of Liquid Chromatography & Related Technologies 31 (1), 79-96, 2007
MCM proteins as diagnostic and prognostic tumor markers in the clinical setting.
C Giaginis, S Vgenopoulou, P Vielh, S Theocharis
Histology and histopathology 25 (3), 351-370, 2010
Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis?
M Mantzorou, A Koutelidakis, S Theocharis, C Giaginis
Nutrition and cancer 69 (8), 1151-1176, 2017
Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data
M Mantzorou, E Pavlidou, G Vasios, E Tsagalioti, C Giaginis
Phytotherapy Research 32 (6), 957-975, 2018
Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity
C Giaginis, M Georgiadou, K Dimakopoulou, G Tsourouflis, E Gatzidou, ...
Digestive diseases and sciences 54 (2), 282-291, 2009
Heat Shock Protein-27,-60 and-90 expression in gastric cancer: association with clinicopathological variables and patient survival
C Giaginis, SS Daskalopoulou, S Vgenopoulou, I Sfiniadakis, G Kouraklis, ...
BMC gastroenterology 9 (1), 1-10, 2009
NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links
I Pateras, C Giaginis, C Tsigris, E Patsouris, S Theocharis
Expert Opinion on Therapeutic Targets 18 (9), 1089-1101, 2014
MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker
C Giaginis, A Giagini, G Tsourouflis, E Gatzidou, E Agapitos, G Kouraklis, ...
Digestive diseases and sciences 56 (3), 777-785, 2011
Lipophilicity and biomimetic properties to support drug discovery
F Tsopelas, C Giaginis, A Tsantili-Kakoulidou
Expert opinion on drug discovery 12 (9), 885-896, 2017
Clinical significance of HuR expression in human malignancy
I Kotta-Loizou, C Giaginis, S Theocharis
Medical oncology 31 (9), 1-19, 2014
Current evidence on the anticancer potential of Chios mastic gum
C Giaginis, S Theocharis
Nutrition and cancer 63 (8), 1174-1184, 2011
Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis
C Giaginis, A Giagini, S Theocharis
Pharmacological Research 60 (3), 60-69, 2009
Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography …
D Vrakas, C Giaginis, A Tsantili-Kakoulidou
Journal of Chromatogry A 1116 (1-2), 158-164, 2006
Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and …
C Giaginis, N Tsoukalas, E Bournakis, P Alexandrou, N Kavantzas, ...
BMC clinical pathology 14 (1), 1-12, 2014
Clinical significance of ephrin (eph)-A1,-A2,-a4,-a5 and-a7 receptors in pancreatic ductal adenocarcinoma
C Giaginis, G Tsourouflis, A Zizi-Serbetzoglou, G Kouraklis, ...
Pathology & Oncology Research 16 (2), 267-276, 2010
Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism
C Giaginis, A Tsantili-Kakoulidou, S Theocharis
Fundamental and Clinical Pharmacology 21 (3), 231-244, 2007
Epithelial–mesenchymal transition in non small-cell lung cancer
N Tsoukalas, E Aravantinou-Fatorou, M Tolia, C Giaginis, ...
Anticancer Research 37 (4), 1773-1778, 2017
The system can't perform the operation now. Try again later.
Articles 1–20